Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 118   

Articles published

4502 5,596.00 -249.00 (-4.26%)
price chart
Analysis and Takeda Pharmaceutical Co Ltd (ADR) (TKPYY) Earnings Review
Analysts await Takeda Pharmaceutical Co Ltd (ADR) (TKPYY) to reports earnings on February, 4. The stock increased 1.77% or $0.42 on February 2, hitting $24.38.
Takeda Pharmaceutical Co Ltd (TKPYY) Upgraded to "Hold" by Zacks Investment ...
Takeda Pharmaceutical Co Ltd logo Zacks Investment Research upgraded shares of Takeda Pharmaceutical Co Ltd (OTCMKTS:TKPYY) from a sell rating to a hold rating in a research report released on Sunday, AnalystRatings.
Takeda Pharmaceutical Co Ltd (TKPYY) Raised to Hold at Zacks Investment Research  Zolmax
Takeda and Nanotherapeutics Announce Agreement to Expand Takeda's ...
ALACHUA, Fla. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (Takeda) (TOKYO: 4502) and Nanotherapeutics, Inc., announced an agreement providing Takeda with expanded commercialization and technology access ...
Takeda Announces Sale of Respiratory Portfolio to AstraZeneca
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced that it has entered into a definitive agreement to sell its respiratory portfolio to AstraZeneca.
AstraZeneca to buy Takeda's lung business for �383m  Telegraph.co.uk
AstraZeneca to strengthen therapy area franchise through acquisition of ...  FiercePharma
Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO: 4502) ("Takeda") today announced that Christophe Weber, President and Chief Executive Officer of Takeda, will make a formal presentation on January 12, local time, ...
Takeda Pharmaceutical: New Drug Application Approval in Japan for Copaxone ...
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) today obtained the New Drug Application approval for Copaxone� Subcutaneous Injection 20 mg Syringe (generic name: glatiramer acetate), a drug for the ...
Invest like Larry Robbins: Teva Pharmaceutical Industries Ltd (ADR) (TEVA ...  CNA Finance (press release)
Teva Receives Approval to Market Copaxone in Japan  Jewish Business News
Takeda and Cour Partner to Develop Novel Therapies for Celiac Disease and ...
OSAKA, Japan & CHICAGO--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) and Cour Pharmaceutical Development Company, Inc. today announced a partnership to research and develop novel immune modulating therapies ...
Moody's: Takeda's rating not immediately impacted by ACTOS settlement ...
Tokyo, May 01, 2015 -- Moody's Japan K.K. says that the A1 issuer and senior unsecured debt ratings as well as (P)A1 shelf registration of Takeda Pharmaceutical Company Limited ("Takeda") will not be immediately impacted following its 28 April 2015 (U ...
Takeda Pharma drops on $2.7bn charge to settle Actos lawsuits  International Business Times UK
Takeda Falls on $2.7 Billion Charge to Settle Actos Lawsuits  Bloomberg
Takeda to Present Data from Ixazomib's Phase 3 Study in Relapsed/Refractory ...
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of ...
Aquinnah Pharmaceuticals Receives $5 Million Investment from Takeda ...
CAMBRIDGE, Mass., Dec. 21, 2015 /PRNewswire/ -- Aquinnah Pharmaceuticals announced today that it has received a $5 Million investment from Takeda Pharmaceutical Company, Limited, in it's first private equity financing. The company has assembled a ...
Aquinnah secures $5 million private equity investment from Takeda  News-Medical.net